Five Prime Therapeutics Inc (FPRX)

NASDAQ
38.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    37.95 - 38.01

FPRX Overview

Prev. Close
38
Day's Range
37.95-38.01
Revenue
18.65M
Open
37.99
52 wk Range
3.64-38.9
EPS
-2.29
Volume
0
Market Cap
1.77B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
556,637
P/E Ratio
-
Beta
4.57
1-Year Change
606.32%
Shares Outstanding
46,572,029
Next Earnings Date
Aug 11, 2021
What is your sentiment on Five Prime Therapeutics Inc?
or
Vote to see community's results!

Five Prime Therapeutics Inc News

Five Prime Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary

Five Prime Therapeutics Inc Company Profile

Five Prime Therapeutics Inc Company Profile

Employees
51

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. The Company’s primary focus is on researching and developing immuno-oncology and targeted cancer therapies. The Company’s pipeline includes Bemarituzumab (FPA144), which is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that it is studying in a clinical trial in combination with 5-fluorouracil (5-FU), leucovorin and oxaliplatin; FPA150, which is a CD8 T cell checkpoint inhibitor antibody that targets B7-H4; FPT155, which is a soluble CD80 fusion protein that enhances co-stimulation of T cells through CD28; Cabiralizumab (FPA008), which is an antibody that inhibits colony stimulating factor-1 receptor, that it is studying in clinical trials, and BMS-986258, which is an anti-T cell immunoglobulin and mucin domain-3, or TIM-3 antibody.

Read More
  • I's going back to 5.
    2
    • will it go back to 23?
      1
      • when the dilution is over, usually take some days. When Bio sector come back for gaining, it will follow.
        0
    • down trend, I got 10 Puts, may be oversold on next week. Time to fill its gaps.
      0
      • 5,000,000 shares of its common stock in an underwritten public offering in the offering a 30-day option to purchase up to an additional 750,000 shares of common stock offered in the public offering.
        1
        • Article? Link ?
          0
        • Sky Emperor offering price is $21 just posted today. Do your own DD. I will try to do but been busy today
          0
        • Sky Emperor https://finance.yahoo.com/news/five-prime-announces-pricing-upsized-030000081.html
          0
      • Nov 11th, my bad.
        0
        • Offering was yesterday Nov 10th - 5 Mil = 750,000 shares within 30 days, dilution.
          0
          • Time to drop, also offering can happen anytime by now.
            0
            • Short or you’ll miss
              0
              • yesterday i shorted and loss also bettertoshort @30
                0
            • The news about the biontech vaccine is said to be false.
              0
              • Link please?
                0
              • ha ha they don't make vaccines petros...she is confused they have a medicine against cancer
                0
              • Such a strong statement needs link and facts that is not the competition trying to under mine it
                0
            • ok I bought 40 shares at 18....just for fun....ha ha
              0
              • Den ksero KATHOLOU tin "DE HIRO". paizo me eurobank equities (den exein pre) KAI me tin exante (exei). Exo filo pou tin antiprosopeyei ellada an thes na sas fero se epafi.
                0
              • Ypotheto itheles na peis "degiro". Episis me tin empeiria mou OS tora me agores poliseis pre / after. Den to synisto. 1 kerdizeis 10 xaneis. Se pre/after Mia megali paraggelia allazei dramatika tin timi.
                0
              • Kali Ora simera itan oli I texnologia Kato sto pre KAI o nasdaq arnitikos. Sto anoigma gyrisan Ola ta xartia thetika. Exo poulisei etsi pre kai mou pige apo -3% pre se +7% synedriasi
                0
            • if it drops at 20 i will buy some....this isnt pump and dump....they cured some cancer at clinical trials.....they have a press conference on a while
              0
              • Sky EmperorNo, because hes not bought any yet im assuming haha
                0
              • There you go George is below 19
                0
              • Hope you will see what we are trying to tell you George. Not an ideal idea to “chase” the market. Also i saw your comment saying you bought it at 18 for fun? I highly reccommend not to buy a stock that you dont even know than just knowing theres so good news about it. Anyway, if you do earn some profit, good for you my friend, however, if you lose, im sorry and we have warned you. All the best buddy!
                0
            • +390% PM
              0
              • Another inflammation biotech, chart is looking good, getting lots of support. At $6.56.
                0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.